Vault-13

Checkpoint Capital L.P.

SAN FRANCISCO, CA · CIK 1977548 · 13F filing filed 2024-08-14

SEC-registered investment adviser since 2025 · limited partnership

As an employer

$165.9m reported value +10.9% vs Q1 2024
16positions
95.1%in top 10
5 new 7 added 3 reduced 6 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 922,100 $37.9m22.82% 22.82% AddedShares held: Q3 2023 —, Q4 2023 730.0k, Q1 2024 825.5k, Q2 2024 922.1k +96.6k +96,600 11.7%
2 ARGENX SE SPONSORED ADR ARGX ARGX 82,150 $35.3m21.30% 21.30% AddedShares held: Q3 2023 —, Q4 2023 70.0k, Q1 2024 82.0k, Q2 2024 82.2k +150 +150 0.2%
3 AXSOME THERAPEUTICS INC COM AXSM AXSM 290,772 $23.4m14.11% 14.11% AddedShares held: Q3 2023 —, Q4 2023 155.3k, Q1 2024 132.4k, Q2 2024 290.8k +158.3k +158,335 119.5%
4 AVADEL PHARMACEUTICALS PLC COM SHS AVDL AVDL 1,138,178 $16.0m9.65% 9.65% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 1.1m
5 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 355,000 $12.3m7.42% 7.42% AddedShares held: Q3 2023 —, Q4 2023 266.9k, Q1 2024 280.3k, Q2 2024 355.0k +74.7k +74,699 26.6%
6 CYTOKINETICS INC COM NEW CYTK CYTK 190,000 $10.3m6.21% 6.21% UnchangedShares held: Q3 2023 —, Q4 2023 230.0k, Q1 2024 190.0k, Q2 2024 190.0k
7 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 875,000 $9.0m5.43% 5.43% AddedShares held: Q3 2023 —, Q4 2023 359.4k, Q1 2024 445.2k, Q2 2024 875.0k +429.8k +429,839 96.6%
8 CORCEPT THERAPEUTICS INC COM CORT CORT 244,750 $8.0m4.79% 4.79% ReducedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 273.8k, Q2 2024 244.8k -29.0k -29,026 -10.6%
9 ATYR PHARMA INC COM NEW ATYR ATYR 1,946,477 $3.0m1.83% 1.83% AddedShares held: Q3 2023 —, Q4 2023 1.5m, Q1 2024 1.4m, Q2 2024 1.9m +500.0k +500,000 34.6%
10 PLIANT THERAPEUTICS INC COM PLRX PLRX 232,200 $2.5m1.50% 1.50% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 232.2k
11 KYMERA THERAPEUTICS INC COM KYMR KYMR 82,000 $2.4m1.48% 1.48% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 82.0k
12 CIDARA THERAPEUTICS INC COM NEW CDTX CDTX 145,417 $1.7m1.05% 1.05% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 145.4k
13 TREVI THERAPEUTICS INC COM TRVI TRVI 500,089 $1.5m0.90% 0.90% ReducedShares held: Q3 2023 —, Q4 2023 1.3m, Q1 2024 506.1k, Q2 2024 500.1k -6.0k -5,993 -1.2%
14 APPLIED THERAPEUTICS INC COM APLT APLT 227,470 $1.1m0.64% 0.64% AddedShares held: Q3 2023 —, Q4 2023 0, Q1 2024 220.0k, Q2 2024 227.5k +7.5k +7,470 3.4%
15 SOLENO THERAPEUTICS INC COM SLNO SLNO 19,695 $803.6k0.48% 0.48% NewShares held: Q3 2023 —, Q4 2023 0, Q1 2024 0, Q2 2024 19.7k
16 ALLAKOS INC COM ALLKG ALLKG 649,957 $650.0k0.39% 0.39% ReducedShares held: Q3 2023 —, Q4 2023 444.8k, Q1 2024 768.0k, Q2 2024 650.0k -118.0k -118,007 -15.4%

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
AVADEL PHARMACEUTICALS PLC 701,387 $11.8m701.4k shares
MIRUM PHARMACEUTICALS INC MIRM MIRM 362,193 $9.1m362.2k shares
IRONWOOD PHARMACEUTICALS INC IRWD IRWD 618,528 $5.4m618.5k shares
VERASTEM INC VSTM VSTM 168,739 $2.0m168.7k shares
GH RESEARCH PLC GHRS GHRS 185,653 $2.0m185.7k shares
ATARA BIOTHERAPEUTICS INC 892,853 $619.6k892.9k shares